Almost 13 years ago (feeling very old), I started my journey at university as a naive and optimistic 19 year old… it has been a long, topsy-turvy road but I can now finally cap it all off as Dr. Docherty 🧪 👨🎓
Thank you to everyone that has supported me throughout!!
CHAMPIONS AGAIN!
🏆 Celtic are crowned Champions of Scotland for the FIFTH season in a row!
Huge congratulations to Martin O’Neill and the Bhoys
#Champion5 | #CelticFC🍀🏆
Excited to share my first @biorxivpreprint since joining the @SashaZhernakova lab!
We investigate prophage dynamics and stability in Bifidobacterium longum subspecies (including the novel BL. nexti) across the first year of life in LLNEXT infants. 🦠🧬
biorxiv.org/content/10.64898…
To turn spatial data into a 3D object, check our protocol (open source, napari plug-in). @GuignardLab@adrianobolondi@IBDMmarseille
For example, if you have spatial RNA-seq as sections, you can align them automatically to analyse directly in 3D.
bio-protocol.org/e5607
Happy to share that my postdoctoral work is now out in @ScienceMagazine. We show that the RNA-programmable bridge recombinase ISCro4 can insert, delete, or invert multi-kilobase DNA fragments at defined genomic sites in human cells.
Study link: science.org/doi/10.1126/scie…
CRISPR-Cas has transformed genome editing, but many diseases involve diverse patient-specific mutations within the same gene. A mutation-agnostic alternative is to insert a healthy gene copy at a defined genomic locus, but gene-sized, site-specific insertions remain a major challenge.
Main findings of our work:
(1) ISCro4 is highly active in human cells and can be delivered by plasmid or all-RNA formats
(2) Proof-of-concept programmable multi-kb insertions, deletions, and inversions
(3) Structural insights into the basis of enhanced ISCro4 activity
(4) Specificity and off-target characterisation
(5) A framework to support future development and adoption of bridge recombinases
The work was made possible through a close collaboration between the Jinek Lab, @schwanklab, and @jcornlab. I am deeply grateful to all of my co-authors for the team spirit, hard work, and dedication that went into this publication: @talasandris, Javier Fernández Carrera, @nicopmat, Lilly van de Venn, Charles Yeh, @p_kulcsar, @marquark, @YanikWeber, @SaskiaGerecke, Isabelle Harvey-Seutcheu, Dominic Mailänder, @MorPfl, and @ChrisChanez89. Special thanks to my supervisor, Prof. Martin Jinek, for his outstanding mentorship, and to Prof. Gerald Schwank and Prof. Jacob Corn for their generous support throughout. Finally, I would like to thank everyone in the Jinek lab for creating a supportive work environment, and @EMBO for funding my postdoctoral work.
In parallel, independent work led by @ntperry13, @SKonermann and @pdhsu also reported ISCro4 activity in human cells, reinforcing the robustness and momentum of this direction.
Please reach out if you would like to test the system or discuss potential applications. Relevant plasmids are now available via @Addgene.
One week left to apply for the postdoc position at MRC-LMB in Cambridge. Join our team for an exciting project on transcription-coupled splicing to understand human gene regulation 🧬
#postdoc#cryoEM#biochemistry
🚨Postdoc opportunity🚨Our lab at MRC-LMB Cambridge is recruting a postdoc to study transcription-coupled splicing using cryoEM and endogenous isolation! 🔬 🧬
Please feel free to get in touch directly #postdoc#cryoEM#biochemistry
Apply here by 11 Feb
nature.com/naturecareers/job…
Announcing our preprint: Predicting evolutionary rate as a pretraining task improves genome language model representations: biorxiv.org/content/10.64898…
Genome language models (gLMs) have the potential to further understanding of regulatory genomics without requiring labeled data...
📢 2 PhD Positions - Plant Immune Receptor Bioengineering at Imperial College London
🌱 Start: Oct 2026
📅 Deadline: 10 Feb 2026
🇬🇧 UK/settled status only
💰 Fully funded (48 months)
ℹ️ shorturl.at/po61I#PlantImmunity#PlantPathology
🙏 Share with interested candidates!
🔊 Job Opportunity: Postdoctoral Research Fellow in Bacterial Evolution.
Looking to recruit a postdoc to join a UKRI FLF-funded project on antibiotic resistance evolution in the microbiome 🦠
3 years funding, deadline 26th Jan, please share!
hrwebapp.qub.ac.uk/tlive_web…
When planning your bulk RNAseq experiments for 2026, make sure they're not under-powered. If they are, >50% of your positives will be false, and you'll miss >50% of truly perturbed genes.
nature.com/articles/s41467-0…